Patients showed effects of mitochondrial source of oxidative stress as well as metabolic dysregulation as seen with NLRP3 and FGF23 upregulation, more in CKD than in CKDu, pointing at different triggers of oxidative stress in the two disease subtypes. Here, FGF23 is linked to chronic kidney disease.